Nov. 22 at 12:21 AM
$EDSA Alright; let me hit ya'll with a bullish "long shot"...
The timing of the P3 data drop, renewed lobbying blitz, and now BARDA trial pushback is interesting....
Par to HC "Look, these idiot American's can't get anything right. BARDA trial is ongoing, but years in the process. We've shown meaningful ARR/RRR in severe ARDS patients with an excellent safety profile. As Canadians, we need to be thinking about our own natsec and pandemic preparedness. Can you greenlight an all cause ARDS P3 with ~600 patients? That will have enough powering to show clear benefit. We have prior human evidence, an ongoing P2 sponsored by BARDA to bolster a future submission, and a cause agnostic MoA (TLR4). Thoughts?"
Par to SIF/ISED "See above. We're a small company with a potentially life saving drug. We have invested in and remained loyal to Canada. We need support to conduct this trial, create jobs, and setup self sufficient mfg. Call ABCL too and let's get this done.
$100M should do it."
